发明名称 |
Inhibition of MyBP-C binding to myosin as a treatment for heart failure |
摘要 |
The present invention provides for methods of treating and slowing the onset of heart failure. The inventors have determined that myosin binding to unphosphorylated Myosin Binding Protein C (MyBP-C) plays a key role in the diminution of cardiac contractile force and frequency in heart failure. The present invention provides peptide inhibitors of the MyBP-C/myosin interaction, thereby increasing both cardiac contractile force and frequency in the failing heart, as well as in patients not yet exhibiting frank heart failure. |
申请公布号 |
US9051387(B2) |
申请公布日期 |
2015.06.09 |
申请号 |
US201313827023 |
申请日期 |
2013.03.14 |
申请人 |
Wisconsin Alumni Research Foundation |
发明人 |
Moss Richard L.;Fernandez Ariel |
分类号 |
A61K38/17;A61P9/04;A61K38/08;A61K38/10;A61K45/06;C07K7/06;C07K7/08;C07K14/47 |
主分类号 |
A61K38/17 |
代理机构 |
Parker Highlander PLLC |
代理人 |
Parker Highlander PLLC |
主权项 |
1. A method of treating heart failure comprising:
(a) identifying a patient exhibiting one or more symptoms of heart failure; and (b) administering to said patient a peptide of no more than 50 residues that comprises the MyBP-C binding site for myosin and binds to myosin and comprises the sequence LKKRDXFRRD (SEQ ID NO: 1), where X is A, V or D. |
地址 |
Madison WI US |